These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23153851)

  • 1. "Super-responders" and "hypo-responders": neglecting the obvious question?
    Lim S
    J Am Coll Cardiol; 2012 Nov; 60(21):2258; author reply 2258-9. PubMed ID: 23153851
    [No Abstract]   [Full Text] [Related]  

  • 2. Foreseeing super-response to cardiac resynchronization therapy: a perspective for clinicians.
    Ellenbogen KA; Huizar JF
    J Am Coll Cardiol; 2012 Jun; 59(25):2374-7. PubMed ID: 22698491
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with and without super-response to CRT-D.
    Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
    Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre.
    Steffel J; Milosevic G; Hürlimann A; Krasniqi N; Namdar M; Ruschitzka F; Lüscher TF; Duru F; Holzmeister J; Hürlimann D
    Heart; 2011 Oct; 97(20):1668-74. PubMed ID: 21821856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment.
    van der Heijden AC; Höke U; Thijssen J; Borleffs CJ; van Rees JB; van der Velde ET; Schalij MJ; van Erven L
    Eur J Heart Fail; 2014 Oct; 16(10):1104-11. PubMed ID: 25138313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Kutyifa V; Goldenberg I; Moss AJ
    Trends Cardiovasc Med; 2016 Feb; 26(2):137-46. PubMed ID: 26051208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Real world" experience in Cardiac Resynchronization Therapy at a Swiss Tertiary Care Center.
    Winnik S; Elsener C; Seifert B; Starck C; Straub A; Saguner AM; Breitenstein A; Krasniqi N; Wilhelm MJ; Haegeli L; Duru F; Benussi S; Maisano F; Lüscher TF; Holzmeister J; Huerlimann D; Ruschitzka F; Steffel J
    Swiss Med Wkly; 2017; 147():w14425. PubMed ID: 28421570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular endocardial pacing via the interventricular septum for cardiac resynchronization therapy: first report.
    Gamble JH; Bashir Y; Rajappan K; Betts TR
    Heart Rhythm; 2013 Dec; 10(12):1812-4. PubMed ID: 23891954
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure.
    Choi AJ; Thomas SS; Singh JP
    Heart Fail Clin; 2016 Jul; 12(3):423-36. PubMed ID: 27371518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure.
    Suzuki H; Nodera M; Kamioka M; Kaneshiro T; Kamiyama Y; Takeishi Y
    Heart Vessels; 2017 Aug; 32(8):926-931. PubMed ID: 28181011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Vulnerable Phase of Heart Failure.
    Gracia E; Singh P; Collins S; Chioncel O; Pang P; Butler J
    Am J Ther; 2018; 25(4):e456-e464. PubMed ID: 29985824
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary venoplasty-assisted implantation of cardiac resynchronization device in a patient with persistent left superior vena cava.
    Cagin C; Barsness GW; Friedman PA; Cha YM
    Heart Rhythm; 2010 Jan; 7(1):141-2. PubMed ID: 19726238
    [No Abstract]   [Full Text] [Related]  

  • 17. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gated SPECT left ventricular shape and prediction of super responders to cardiac resynchronization therapy: Not so easy as it (LV) looks.
    Altawil M; Greenberg J; Ananthasubramaniam K
    J Nucl Cardiol; 2022 Aug; 29(4):1547-1551. PubMed ID: 33608854
    [No Abstract]   [Full Text] [Related]  

  • 19. What We Can Learn from "Super-responders".
    Proclemer A; Muser D; Facchin D
    Heart Fail Clin; 2017 Jan; 13(1):225-232. PubMed ID: 27886927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization revisited: what is the next step?
    Linde C
    Eur J Heart Fail; 2015 Sep; 17(9):881-3. PubMed ID: 26289768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.